| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel
1 company
Mahon Paul A serves as an EVP &General Counsel at UTHR. Across recent SEC filings that breaks down to 0 buys and 400 sells. Those positions are worth an estimated $26.4M at current prices.
Historically, Mahon Paul A's trades have earned a below-average insider score of 46/100 across 84 rated trades. Over a 12-month horizon, 15.5% of those trades were profitable, with an average 12-month return of -30.5%.
The biggest single holding is UTHR (~$26.4M) as EVP &General Counsel. The recent filings there lean toward selling, a net 565,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $544.30 | $4,517,708.96 | -15.5% | - | - | |
| Oct 1, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $564.95 | $4,689,050.65 | -15.5% | - | - | |
| Sep 17, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $497.54 | $4,129,607.97 | -15.5% | - | - | |
| Sep 3, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $482.03 | $4,000,836.38 | -15.5% | - | - | |
| Aug 20, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $523.14 | $4,342,079.03 | -15.5% | - | - | |
| Aug 6, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 7,003 | $517.32 | $3,622,809.97 | -13.4% | - | - | |
| Jul 16, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $533.69 | $4,429,637.90 | -15.5% | +2.1% | - | |
| Jul 2, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $552.56 | $4,586,274.68 | -15.5% | -2.5% | - | |
| Jun 18, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $541.55 | $4,494,840.76 | -15.5% | -7.1% | - | |
| Jun 4, 2026 | UTHR United Therapeutics Corporation | EVP &General Counsel | Sale+OE | 8,300 | $547.07 | $4,540,642.41 | -15.5% | -10.2% | - |